Deutsche Bank’s Maze Therapeutics MAZE Stock Holding History
Bought
Maintained
Sold
Other funds holding MAZE
Deutsche Bank's MAZE Position: Q3 2026 in Review
Deutsche Bank reduced its Maze Therapeutics (MAZE) stake by 8% in Q3 2026, selling an estimated $77.4K and leaving 32,205 shares worth $875K. The position accounts for ﹤0.01% of the portfolio, ranked #2311.
Deutsche Bank first reported a position in MAZE in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.04M in Q2 2026. 158 funds tracked by Wall St. Rank hold MAZE as of Q3 2026.
- Deutsche Bank held 32,205 shares of Maze Therapeutics worth $875K as of Q3 2026.
- Deutsche Bank sold 2,788 Maze Therapeutics shares in Q3 2026, an estimated $77.4K.
- Maze Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #2311 holding.
- Deutsche Bank first reported a position in Maze Therapeutics in Q1 2025 and has held it in 7 quarters since.
- Deutsche Bank's Maze Therapeutics position peaked at $1.04M in Q2 2026.
- 158 funds tracked by Wall St. Rank held Maze Therapeutics as of Q3 2026.
Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.